A detailed history of Thompson Siegel & Walmsley LLC transactions in Iqvia Holdings Inc. stock. As of the latest transaction made, Thompson Siegel & Walmsley LLC holds 278,994 shares of IQV stock, worth $61.5 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares
278,994
Previous 269,321 3.59%
Holding current value
$61.5 Million
Previous $42.4 Million 24.86%
% of portfolio
0.86%
Previous 0.71%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 12, 2025

BUY
$157.68 - $200.82 $1.53 Million - $1.94 Million
9,673 Added 3.59%
278,994 $53 Million
Q2 2025

Aug 06, 2025

BUY
$137.0 - $174.37 $10.5 Million - $13.3 Million
76,426 Added 39.62%
269,321 $42.4 Million
Q1 2025

May 09, 2025

BUY
$176.3 - $209.96 $11.6 Million - $13.9 Million
66,050 Added 52.07%
192,895 $34 Million
Q4 2024

Feb 10, 2025

BUY
$190.97 - $236.63 $20 Million - $24.7 Million
104,553 Added 469.02%
126,845 $24.9 Million
Q3 2024

Nov 12, 2024

BUY
$206.81 - $251.55 $827,240 - $1.01 Million
4,000 Added 21.87%
22,292 $5.28 Million
Q2 2024

Aug 08, 2024

BUY
$211.18 - $248.87 $547,378 - $645,071
2,592 Added 16.51%
18,292 $3.87 Million
Q4 2023

Feb 07, 2024

SELL
$177.16 - $232.73 $389,752 - $512,006
-2,200 Reduced 12.29%
15,700 $3.63 Million
Q3 2023

Nov 08, 2023

BUY
$196.75 - $231.96 $1.79 Million - $2.11 Million
9,100 Added 103.41%
17,900 $3.52 Million
Q2 2023

Aug 10, 2023

SELL
$183.66 - $224.77 $146,928 - $179,816
-800 Reduced 8.33%
8,800 $1.98 Million
Q1 2023

May 11, 2023

BUY
$188.0 - $240.65 $1.8 Million - $2.31 Million
9,600 New
9,600 $1.91 Million
Q1 2022

Apr 26, 2022

SELL
$210.56 - $273.58 $631 - $820
-3 Closed
0 $0
Q1 2021

May 07, 2021

BUY
$173.0 - $194.59 $519 - $583
3 New
3 $1,000

Others Institutions Holding IQV

About IQVIA HOLDINGS INC.


  • Ticker IQV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 185,740,000
  • Market Cap $41B
  • Description
  • IQVIA Holdings Inc. provides advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The ...
More about IQV
Track This Portfolio

Track Thompson Siegel & Walmsley LLC Portfolio

Follow Thompson Siegel & Walmsley LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thompson Siegel & Walmsley LLC, based on Form 13F filings with the SEC.

News

Stay updated on Thompson Siegel & Walmsley LLC with notifications on news.